PAK1 and breast cancer: Inhibitors of PAK1, a downstream effector in the Ras pathway, have also been reported to suppress the growth of NF1-deficient MPNST cells as well as neurofibromin-deficient human breast cancer (MDA-MB-231) xenografts in mice.